Zerocancer.org: “African Americans and Prostate Cancer.”
Dana-Farber Cancer Institute: “What African American Men Need to Know About Prostate Cancer,” “Prostate cancer scoring method may underestimate mortality risk in black men.”
National Cancer Institute: “African American Men More Likely to Die from Low-Grade Prostate Cancer.”
American Cancer Society: “American Cancer Society Recommendations for Prostate Cancer Early Detection.”
European Urology: “Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.”
Memorial Sloan Kettering Cancer Center: “4 Things African American Men Should Know about Prostate Cancer.”
Moffitt Cancer Center: “Saturation Biopsy for Prostate Cancer.”
Urology: “Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?”
Prostate Cancer and Prostatic Diseases: “The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.”
Translational Urology and Andrology: “Rethinking active surveillance for prostate cancer in African American men.”
Brandon A. Mahal, MD, radiation oncologist, Dana-Farber Cancer Institute, Boston.
Lorelei Mucci, ScD, associate professor of epidemiology, Harvard School of Public Health; leader, cancer epidemiology, Dana-Farber/Harvard Cancer Center, Boston.
Kosj Yamoah, MD, PhD, radiation oncologist, Moffitt Cancer Center, Tampa, FL.